MADHAVI CHILAKAMARRI

Allopathic & Osteopathic Physicians|Internal Medicine FORT WAYNE, IN NPI 1013916394

General Payments — all program years on this page

$951.12

  • Category: General Payments
  • Program years: PY2018–2019
  • Record count: 77
  • As of (CMS publication): 2026-01-23

Latest program year (PY2019): $237.77 across 15 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2019) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $237.7715

By paying entity

Latest program year (PY2019) · sorted by reported total.

Paying entityAmountRecords
NOVARTIS PHARMACEUTICALS CORPORATION $68.504
Novo Nordisk AS $63.873
Acerta Pharma LLC $44.673
Genentech USA, Inc. $22.162
GlaxoSmithKline, LLC. $16.201
Allergan Inc. $11.261
PFIZER INC. $11.111

By program year

Program yearAmountRecords
2018 $713.3562
2019 $237.7715

Records — PY2019 (15)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
659035067 Novartis Pharmaceuticals Corporation $13.75 06/04/2019 Food and Beverage Undisputed 01/23/2026 View at CMS
659035069 Novartis Pharmaceuticals Corporation $16.75 03/04/2019 Food and Beverage Undisputed 01/23/2026 View at CMS
659035073 Novartis Pharmaceuticals Corporation $18.00 04/12/2019 Food and Beverage Undisputed 01/23/2026 View at CMS
659035077 Novartis Pharmaceuticals Corporation $20.00 01/14/2019 Food and Beverage Undisputed 01/23/2026 View at CMS
668738405 Novo Nordisk Inc $21.15 02/11/2019 Food and Beverage Undisputed 01/23/2026 View at CMS
668738407 Novo Nordisk Inc $21.21 02/22/2019 Food and Beverage Undisputed 01/23/2026 View at CMS
669539527 Novo Nordisk Inc $21.51 04/08/2019 Food and Beverage Undisputed 01/23/2026 View at CMS
670183919 Allergan Inc. $11.26 08/02/2019 Food and Beverage Undisputed 01/23/2026 View at CMS
671084789 GlaxoSmithKline, LLC. $16.20 07/08/2019 Food and Beverage Undisputed 01/23/2026 View at CMS
673747051 PFIZER INC. $11.11 02/22/2019 Food and Beverage Undisputed 01/23/2026 View at CMS
681148261 Genentech USA, Inc. $11.12 02/13/2019 Food and Beverage Undisputed 01/23/2026 View at CMS
685116971 AstraZeneca Pharmaceuticals LP $12.80 03/20/2019 Food and Beverage Undisputed 01/23/2026 View at CMS
685515919 AstraZeneca Pharmaceuticals LP $18.87 01/25/2019 Food and Beverage Undisputed 01/23/2026 View at CMS
685722209 AstraZeneca Pharmaceuticals LP $13.00 01/16/2019 Food and Beverage Undisputed 01/23/2026 View at CMS
708852321 Genentech USA, Inc. $11.04 12/05/2019 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2019_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.